GLOBALT Investments LLC GA Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

GLOBALT Investments LLC GA grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 112.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,903 shares of the healthcare conglomerate's stock after buying an additional 6,819 shares during the quarter. GLOBALT Investments LLC GA's holdings in UnitedHealth Group were worth $7,544,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its position in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate's stock worth $12,893,331,000 after purchasing an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock valued at $4,094,247,000 after acquiring an additional 35,533 shares in the last quarter. International Assets Investment Management LLC raised its holdings in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Dimensional Fund Advisors LP grew its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. increased its stake in UnitedHealth Group by 0.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock valued at $1,920,039,000 after purchasing an additional 21,149 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.2 %

NYSE:UNH traded down $1.12 during trading hours on Monday, reaching $591.11. 1,144,052 shares of the company traded hands, compared to its average volume of 3,876,694. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business's 50-day moving average price is $582.84 and its two-hundred day moving average price is $549.98. The stock has a market capitalization of $543.99 billion, a P/E ratio of 38.29, a P/E/G ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the business earned $6.56 EPS. UnitedHealth Group's revenue was up 9.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's payout ratio is presently 54.72%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th. TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a research report on Friday, October 18th. Cantor Fitzgerald raised their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a report on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 17th. Finally, Morgan Stanley decreased their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.